Press - J.Lamarck

Company
Invest in Biotechnology
Strategy
Service
Press
News
Contact

J. Lamarck S.p.A. - Advisors in Biotech

IT EN NL

Company
Invest in Biotechnology
Strategy
Service
Press
News
Contact

Press

Home
Press

Press

Biotech: The new asset class?
Investment Europe, June 2014

GDPR - COOKIES - ESG
WHISTLEBLOWING

J. Lamarck S.p.A.

Via Anelli, 28
25015 Desenzano del Garda (BS)
Italy
Tel. +39.030.8362633
Fax. +39.030.8362548

N° di iscrizione al registro imprese di Brescia, codice fiscale e partita IVA 02684320233
Capitale sociale di Euro 120.000,00 i.v -
La Società aderisce all'Arbitro delle Controversie Finanziarie (ACF)
Iscritta al N° 7 della sezione delle Società di Consulenza Finanziaria dell'Albo Unico dei Consulenti Finanziari con delibera dell' Ocf N° 961 del 1.12.2018

Subscribe
to newsletter

Copyright © 2024 | J. LAMARCK S.P.A. Powered by Moving

Cookie policy

This website or third-party tools used by this site use cookies that are necessary for its functioning and are useful for the purposes of the site itself. If you want to learn more or deny consent to the use of cookies, see the cookie policy. By closing this banner you consent to the use of cookies.